Formulation development for injectable drug products

Formulation development for injectable drug products
Product Description

An algorithm and science-based high-throughput approach to identify quickly the "sweet spot" (formulational optimum) for intrinsic stability of a biologic molecule.

ProJect Pharmaceutics GmbH

  • Country/Region:
    Germany
  • Founded:
    2010
  • On CPHI since:
    2015
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Specifications
  • Details
    Lead selection in discovery. Pre-clinical screening to turn a drug substance into a stabilized drug product.
    Phase transitions in clinical trials.
    Life cycle management (e.g. from vial into prefilled syringe)

ProJect Pharmaceutics GmbH

  • Country/Region:
    Germany
  • Founded:
    2010
  • On CPHI since:
    2015
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation

More Products from ProJect Pharmaceutics GmbH (1)

  • Lyophilization process development

    Product Lyophilization process development

    An algorithm- and deep-niche knowledge-based approach to come quickly (in only 5 development lyo cycles) to the final most efficient and robust lyophilization cycle tailored to the drug product, which then can easily be transferred to a CMO for GMP manufacturing.

ProJect Pharmaceutics GmbH resources (1)

  • Brochure PJP capabilities in a nutshell

    A glimpse of main services offered by ProJect Pharmaceutics. Projects span from full development projects to short single work package feasibility studies (e.g. proof of concept).We offer a fee-for-service business model, short lead times (2-4 weeks start-up time), and a high budget and timelines compliance.